Jesse Engreitz, Ph.D.
Associate Director of the Novo Nordisk Foundation Center
Jesse Engreitz is currently an assistant professor at Stanford University in the Department of Genetics and the Children’s Heart Center Basic Sciences and Engineering Initiative. Engreitz is also an associate director of the Novo Nordisk Foundation Center for Genomic Mechanisms of Disease at the Broad Institute.
A member of the Broad Institute community since 2010, Engreitz has pioneered CRISPR technologies and computational models to understand the regulatory wiring of the genome. His work has provided fundamental insights into how 3D chromosome conformation, long noncoding RNAs, and enhancers regulate gene expression. At the Broad Institute, Engreitz launched the Variant-to-Function Initiative to connect common disease variants to their molecular and cellular mechanisms.
Engreitz also leads a Functional Characterization Center for the NIH/NHGRI Impact of Genomic Variation on Function Consortium, is a founding member of the International Common Disease Alliance, and is an NIH/NHGRI Genomic Innovator. Previously, Engreitz led a group as a Junior Fellow at the Harvard Society of Fellows, and completed his Ph.D. with Eric Lander in the Harvard-MIT Division of Health Sciences and Technology.